FNBT
KYNB

FineMark National Bank & Trust’s Kyntra Bio KYNB Stock Holding History

FineMark National Bank & Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1
Closed -$1K – 1318
2015
Q4 		$1K Hold
1
– – ﹤0.01% 1260
2015
Q3 		$1K Hold
1
– – ﹤0.01% 1381
2015
Q2 		$1K Buy
+1
New +$582 ﹤0.01% 1332

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FineMark National Bank & Trust's KYNB Position: Q1 2016 in Review

FineMark National Bank & Trust sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 1 share — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in KYNB in Q2 2015 and held it in 3 quarters. The position peaked at $1K in Q4 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • FineMark National Bank & Trust reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1 Kyntra Bio share in Q1 2016, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Kyntra Bio in Q2 2015 and held it in 3 quarters.
  • FineMark National Bank & Trust's Kyntra Bio position peaked at $1K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on FineMark National Bank & Trust's 13F filing for Q1 2016, filed 10 May 2016.